NYSE: PFEPfizer Inc Stock
$51.59+1.50 (+2.99%)
Updated Jun 24, 2022
PFE Price
$51.59
Fair Value Price
N/A
Market Cap
$289.47B
52 Week Low
$38.82
52 Week High
$61.71
P/E
11.62x
P/B
3.51x
P/S
3.14x
PEG
N/A
Dividend Yield
3.06%
Revenue
$92.37B
Earnings
$24.97B
Gross Margin
60.4%
Operating Margin
29.43%
Profit Margin
27%
Debt to Equity
1.23
Operating Cash Flow
$35B
Beta
0.62
Next Earnings
Jul 26, 2022
Ex-Dividend
Jul 28, 2022
Next Dividend
Sep 6, 2022
Zen Score
–
Industry Average (44)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PFE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PFE is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PFE is good value based on its earnings relative to its share price (11.62x), compared to the US market average (20.48x)
P/E vs Market Valuation
PFE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PFE due diligence checks available for Premium users.
PFE News
Valuation
PFE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.62x
Industry
9.02x
Market
20.48x
PFE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PFE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PFE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.51x
Industry
5.43x
PFE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PFE's financial health
Profit margin
Revenue
$25.7B
Net Income
$7.9B
Profit Margin
30.6%
PFE's Earnings (EBIT) of $27.19B... subscribe to Premium to read more.
Interest Coverage Financials
PFE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$183.8B
Liabilities
$101.2B
Debt to equity
1.23
PFE's short-term assets ($54.42B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PFE's long-term liabilities ($61.89B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PFE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PFE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$6.5B
Investing
$567.0M
Financing
-$6.6B
PFE's operating cash flow ($34.58B)... subscribe to Premium to read more.
Debt Coverage Financials
PFE vs General Drug Manufacturer Stocks
Pfizer Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.